SEC Filing Summary: Hexindai Inc. (Form 6-K)
Business Context and Reporting Period
This Form 6-K was filed by Hexindai Inc., a foreign private issuer, for the month of April 2018. The registrant's principal executive office is located in Beijing, People's Republic of China. The filing was signed by Zhang Qisen (Johnson), Chief Financial Officer, on April 12, 2018. The document serves as a report pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document consists primarily of cover page information and an exhibit index.
Material Changes
No material changes versus the prior comparable period are disclosed in the provided text. The filing does not contain comparative financial data or operational updates.
Guidance, Outlook, and Risks
The filing text does not provide guidance, outlook, management commentary, risks, contingencies, or unusual items. The content is limited to the submission of a press release as Exhibit 99.1, the text of which is not included in the input.
Key Facts for Investor Verification
- The registrant is Hexindai Inc., not Akso Health Group as indicated in the request metadata.
- The filing date is April 12, 2018, covering the month of April 2018.
- The filing includes a press release (Exhibit 99.1) which likely contains the substantive information, but the text of the release is not present in the source data.
- No financial figures or operational metrics are available in the provided text.